References
- Aruoma O. I. Dietary management of sickle cell anaemia with vanillin. Free Radical Research Communications 1992
- Hathcock J. N., Rader J. Micronutrient safety. Micronutrients and Immune Function, A. Bendick, R. Chandra. New York Academy of Sciences. 1990; Vol. 587: 257
- Moore R. B., Hulgan T. M., Green J. W., Jenkins L. D. Increased susceptibility of the sickle cell membrane Ca2 + Mg2-ATPase to t-butylhydroperoxide: Protective effects of ascorbate and desferal. Blood 1992; 79: 1334–1341
- Repke T., Hebbel R. T. Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathogenic iron deposits and cytoplasmic reducing agents. Blood 1991; 78: 2753–2758
- Platt O. S., Thorington B. D., Brambilla D. J., Milner P. F., Rosse W. F., Vichinsky E., Kinney T. R. Pain in Sickle Cell Disease. New England Journal of Medicine 1991; 325: 11–16
- Ballas S. K. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am. J. Hematol. 1991; 36: 122–130
- Abraham D. J., Mehanna A. S., Wireko F. C., Whitney J., Thomas R. P., Orringer E. P. Vanillin, a potential agent for the treatment of sickle cell anemia. Blood 1991; 77: 1334–1341
- Swerdlow P. S., Richard L., Adelman B. A., Abraham D. J. Preliminary study of an oral anti-sickling agent in humans. Blood 1991; 78: 415a, (suppl. 1)
- Multicenter Study of Hydroxyurea in Sickle Cell Anemia. NIH Grant, Number UO1 HL45696